跳至主要内容
临床试验/NCT02745106
NCT02745106Unknown2 期

Randomized Pilot Trial of Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy

Novosibirsk Scientific Research Institute for Circulatory Pathology2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年8月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
50
试验地点
2
主要终点
Pulmonary vascular resistance

研究概览

简要总结

The study evaluates the technique of non-drug treatment of residual pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension after pulmonary thromboendarterectomy.

详细描述

The best strategy of treatment patients with chronic thromboembolic pulmonary hypertension is pulmonary thromboendarterectomy. In 5-30% of cases after pulmonary thromboendarterectomy residual pulmonary hypertension is persisted. The technique of radiofrequency pulmonary artery denervation in patients with idiopathic pulmonary arterial hypertension (type I) is known and was assessed during clinical investigation. In this study radiofrequency pulmonary artery denervation technique may be applied in patients with residual pulmonary hypertension after pulmonary thromboendarterectomy (type IV)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • presence of residual pulmonary hypertension in patients after pulmonary thromboendarterectomy according to right heart catheterization: mean pulmonary artery pressure > 25 mm Hg or pulmonary vascular resistance > 400 dyn x sec x cm-5

排除标准

  • no evidence of residual pulmonary hypertension in patients after pulmonary thromboendarterectomy (mean pulmonary artery pressure <25 m Hg).
  • refusal of a patient to participate in the study.
  • the presence of severe concomitant diseases of the cardiovascular system and lungs, leading to pulmonary hypertension
  • the presence of other severe comorbidities that may result in death within a year.

结局指标

主要结局

Pulmonary vascular resistance

时间窗: 12 months

Units - (dyn x sec x cm-5)

次要结局

  • 6-minute walking distance test(12 months)
  • Echocardiographical sings of right ventricle function - 1(12 months)
  • Echocardiographical sings of right ventricle function - 2(12 months)
  • Pulmonary artery pressure(12 months)

研究者

发起方
Novosibirsk Scientific Research Institute for Circulatory Pathology
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alexander Edemskiy

Principal investigator Alexander Edemskiy

Novosibirsk Scientific Research Institute for Circulatory Pathology

研究点 (2)

Loading locations...

相似试验

Interventional Treatment of Residual Pulmonary... | 临床试验